Podcast: Biosimilars and Cost-Savings
North Carolina State Senator Natalie Murdock
Carol Lynch, Sandoz US President, Head Sandoz North America
Pam Traxel, Senior Vice President, American Cancer Society Cancer Action Network
Cheryl Larson, President & CEO of the non-profit Midwest Business Group on Health (MBGH)
Science is forever evolving, particularly when it comes to cutting-edge medicines aimed at improving the quality of life for millions of people. It has been a decade since one innovation entered the picture which has helped save lives while being an affordable option for those living with cancer, arthritis, and auto-immune diseases. Biosimilars are available in almost 100 countries around the world including those in Europe as well as Australia, Canada, Japan, and the US. On this episode of the Women In Government Podcast, our panel discusses how these medicines expand treatment options and can potentially improve patient outcomes by increasing or providing earlier access to therapies.
Biosimilars Resources